Page results
-
Anticoagulants are medicines that help prevent blood clots. They're given to people at a high risk of getting clots, to reduce their chances of developing serious conditions such as strokes and heart attacks.
-
The diagnostic haematology clinics at UCLH perform comprehensive blood testing, including blood film examination, immunophenotyping and molecular testing.
-
Advice on relaxation techniques for young people living with fatigue conditions.
-
Intrauterine insemination (IUI) is a type of fertility treatment. It is commonly used for women who are using donated sperm in their treatment.
-
This page aims to provide information about the syndrome haemophagocytic lymphohistiocytosis (HLH).
-
The UCLH Maternity Voices Partnership (MVP) is a team of women and their families, commissioners and providers (midwives and doctors) working together to review and contribute to the development of local maternity care.
-
The aim of the Integrated Care Operations is to support the development of patient centred co-ordinated care for UCLH patients through collaborative working across the organisation and with the community, social and primary care.
-
A guide created by The Red Cell Network with expert patient insight from Elaine Tappin, Miriam Santos Freire and Nneka Smith.
-
You can make a secure payment using our online portal. It is a convenient way to make a payment for a range of services and is available 24/7. When making a payment you will be directed a secure website hosted by The Access Group, a leading provider of business software. Payments can be made against an invoice raised by the Trust or for a range of other services which are set out when you access the portal.
-
This page has been written for patients who are receiving proton beam therapy (PBT) to the prostate.
File results
-
-
-
-
-
FOI201785 Opthalmology treatments
-
FOI201795 Patient administration system
-
FOI201791 IVF treatment
-
FOI201788 Patient discharge
-
FOI201786 EU national staff leaving posts
-
FOI/2023/0326 - Risk management system reporting rates for adverse events